{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T01:25:50Z","timestamp":1787966750208,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.cgh.2024.01.022","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T01:11:23Z","timestamp":1706836283000},"page":"1210-1216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Study"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-9413","authenticated-orcid":false,"given":"Xiang","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-qian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-sheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-5572","authenticated-orcid":false,"given":"Min","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.cgh.2024.01.022_bib1","article-title":"Epidemiology of Helicobacter pylori infection","volume":"23","author":"Sjomina","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2024.01.022_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10120-018-0876-0","article-title":"Effect of Helicobacter pylori eradication on the incidence of gastric cancer: a systematic review and meta-analysis","volume":"22","author":"Sugano","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.cgh.2024.01.022_bib3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1136\/gutjnl-2017-315363","article-title":"Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population","volume":"67","author":"Doorakkers","year":"2018","journal-title":"Gut"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2024.01.022_bib4","article-title":"Helicobacter pylori infection and nonmalignant diseases","volume":"22","author":"Sjomina","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2024.01.022_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/gastro\/goz057","article-title":"Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy","volume":"8","author":"Tsuji","year":"2020","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.cgh.2024.01.022_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.022_bib7","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1097\/CM9.0000000000002546","article-title":"2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment","volume":"135","author":"Zhou","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cgh.2024.01.022_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2036.2007.03386.x","article-title":"Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori","volume":"26","author":"Fischbach","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.022_bib9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.01.022_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1523-5378.2007.00518.x","article-title":"A\u00a0report card to grade Helicobacter pylori therapy","volume":"12","author":"Graham","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2024.01.022_bib11","first-page":"11","article-title":"Primary antibiotic resistance of Helicobacter pylori in different regions of China: a systematic review and meta-analysis","author":"Chen","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.cgh.2024.01.022_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1523-5378.2007.00508.x","article-title":"Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy","volume":"12","author":"Sugimoto","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2024.01.022_bib13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/apt.13325","article-title":"Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects: a randomised open-label cross-over study","volume":"42","author":"Sakurai","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.01.022_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ph13100276","article-title":"The potential benefits of vonoprazan as Helicobacter pylori infection therapy","volume":"13","author":"Miftahussurur","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.cgh.2024.01.022_bib15","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1159\/000502287","article-title":"Dual therapy with vonoprazan and amoxicillin is as effective as triple therapy with vonoprazan, amoxicillin and clarithromycin for eradication of Helicobacter pylori","volume":"101","author":"Furuta","year":"2020","journal-title":"Digestion"},{"key":"10.1016\/j.cgh.2024.01.022_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12896","article-title":"Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: a prospective, randomized clinical pilot study","volume":"27","author":"Hu","year":"2022","journal-title":"Helicobacter"},{"key":"10.1016\/j.cgh.2024.01.022_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/gutjnl-2019-319954","article-title":"Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan","volume":"69","author":"Suzuki","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.01.022_bib18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00535-020-01709-4","article-title":"Clinical impact of vonoprazan-based dual therapy with amoxicillin for H. pylori infection in a treatment-naive cohort of junior high school students in Japan","volume":"55","author":"Gotoda","year":"2020","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cgh.2024.01.022_bib19","first-page":"12","article-title":"Expectations for the dual therapy with vonoprazan and amoxicillin for the eradication of H. pylori","author":"Furuta","year":"2023","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cgh.2024.01.022_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-023-01074-5","article-title":"Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study","author":"Peng","year":"2023","journal-title":"Clin Exp Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524000995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524000995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:57:09Z","timestamp":1716566229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524000995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1542356524000995"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.022","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Vonoprazan-Amoxicillin Dual Regimen With Varying Dose and Duration for Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}